Skip to content
healthcare.dev
Get a free key

Firdapse

NDC 69616-211, amifampridine phosphate, tablet, from Catalyst Pharmaceuticals, Inc..

Product NDC
69616-211
Status
Listed
Labeler
Catalyst Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA208078
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69616-211 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AMIFAMPRIDINE PHOSPHATE10 mg/1

Pharmacologic classes

Potassium Channel Antagonists [MoA]; Potassium Channel Blocker [EPC]

Package NDCNDC-11Package
69616-211-0369616021103240 TABLET in 1 BOTTLE, PLASTIC (69616-211-03)
69616-211-066961602110612 BLISTER PACK in 1 CARTON (69616-211-06) / 10 TABLET in 1 BLISTER PACK (69616-211-04)
69616-211-086961602110860 TABLET in 1 BOTTLE, PLASTIC (69616-211-08)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f015fe60-3128-4a43-8c31-19fc6b5def3f

Use it

Look up 69616-211 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69616-211 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69616-211. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.